Angiotensin-converting enzyme polymorphisms and their potential impact on left ventricular myocardial geometry after aortic valve surgery

Journal of Heart Valve Disease

Volumn 12, Issue 6, 2003, Pages 687-695

  Knez, Igor ^a,b   Renner, Wilfried ^b   Maier, Robert ^b   Rehak, Peter ^b   Rienmüller, Rainer ^b   Pilsl, Martin ^b   Stanger, Olaf ^b   Mircic, Aleksandar ^b   Dacar, Drago ^b   Szalay, Zoltan ^a   Martinovic, Ivo ^c   Vogt, Paul R ^a   Rigler, Bruno ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Division of Cardiothoracic Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENOMIC DNA;

ADULT; AGE; AGED; ALLELE; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BODY SURFACE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; ELECTRON BEAM TOMOGRAPHY; ENZYME POLYMORPHISM; FEMALE; FOLLOW UP; GENE DELETION; GENE INSERTION; GENE ISOLATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VALVE SURGERY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYNCOPE; THREE DIMENSIONAL IMAGING; THROMBOEMBOLISM; TREATMENT INDICATION;

AGED; ANALYSIS OF VARIANCE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POSTOPERATIVE PERIOD; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VARIATION (GENETICS);

EID: 10744222159     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Spagnuolo M, Kloth H, Taranta A, Doyle E, Pasternack B. Natural history of rheumatic aortic regurgitation: Criteria predictive of death, congestive heart failure and angina in young patients. Circulation 1971;44:368-380
2. Bonow RO, Carabello B, de Leon AC, et al. Guidelines for the management of patients with valvular heart disease. Executive summary report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 1998;98:1949-1984
3. Turina J, Turina M, Rothlin M, et al. Improved late survival in patients with chronic aortic regurgitation by earlier operation. Circulation 1984;70(suppl.I):147-152
4. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991;84:1625-1635
5. Pfeffer MA, Braunwald E, Maye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992:327:669-677
6. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992;71:169-180
7. Knez I, Rienmüller R, Maier R, et al. Left ventricular architecture after valve replacement due to critical aortic stenosis: An approach to dis-/qualify the myth of valve prosthesis-patient mismatch? Eur J Cardiothorac Surg 2001;19:797-805
8. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346
9. Stoica SC, Sharples LD, Ahmed I, Roques F, Large SR, Nashef SA. Preoperative risk prediction and intraoperative events in cardiac surgery. Eur J Cardiothorac Surg 2002;21:41-46
10. Magid NM, Borer JS, Young MS, Wallerson DC, DeMonteiro C. Suppression of protein degradation in progressive cardiac hypertrophy of chronic aortic regurgitation. Circulation 1993;87:1249-1257
11. Adams TD, Yanowitz FG, Fisher AG, et al. Heritability of cardiac size: An echocardiographic and electrocardiographic study of monozygotic and dizygotic twins. Circulation 1985;71:39-44
12. Stangl K, Cascorbi I, Stangl V, et al. A1166C polymorphism of the angiotensin II type 1 receptor gene and risk of adverse events after coronary catheter interventions. Am Heart J 2000;140:170-175
13. Danser AH, Derkx FH, Hense HW, Jeunemaitre X, Riegger GA, Schunkert H. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998;16:1879-1883
14. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin-I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988;85:9386-9390
15. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205
16. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-1388
17. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644
18. Tiret L, Kee F, Poirier O, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341:991-992
19. Lechin ML, Quiñones MA, Omran AO, et al. Angiotensin-I-converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-1812
20. Perticone F, Maio R, Cosco C, et al. Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res 1999;43:192-199
21. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638
22. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90:2622-2628
23. The HOPE (Heart Outcomes Prevention Evaluation) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000;342:145-153
24. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999;150:341-353
25. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability. Circulation 2000;101:1372-1378